WHO Collaborating Centre for Reference and Research on Escherichia and Klebsiella, Department of Microbiology and Infection Control, Statens Serum Institut, DK-2300 Copenhagen S, Denmark.
Microbiol Spectr. 2014 Jun;2(3). doi: 10.1128/microbiolspec.EHEC-0019-2013.
To help assess the clinical and public health risks associated with different Shiga toxin-producing Escherichia coli (STEC) strains, an empirical classification scheme was used to classify STEC into five "seropathotypes" (seropathotype A [high risk] to seropathotypes D and E [minimal risk]). This definition is of considerable value in cases of human infection but is also problematic because not all STEC infections are fully characterized and coupled to reliable clinical information. Outbreaks with emerging hybrid strains continuously challenge our understanding of virulence potential and may result in incorrect classification of specific pathotypes; an example is the hybrid strain that caused the 2011 outbreak in Germany, STEC/EAggEC O104:H4, which may deserve an alternative seropathotype designation. The integration of mobile virulence factors in the stepwise and parallel evolution of pathogenic lineages of STEC collides with the requirements of a good taxonomy, which separates elements of each group into subgroups that are mutually exclusive, unambiguous, and, together, include all possibilities. The concept of (sero)-pathotypes is therefore challenged, and the need to identify factors of STEC that absolutely predict the potential to cause human disease is obvious. Because the definition of hemolytic-uremic syndrome (HUS) is distinct, a basic and primary definition of HUS-associated E. coli (HUSEC) for first-line public health action is proposed: stx2 in a background of an eae- or aggR-positive E. coli followed by a second-line subtyping of stx genes that refines the definition of HUSEC to include only stx2a and stx2d. All other STEC strains are considered "low-risk" STEC.
为了帮助评估不同产志贺毒素大肠杆菌(STEC)菌株相关的临床和公共卫生风险,采用经验分类方案将 STEC 分为五个“血清型”(血清型 A[高风险]至血清型 D 和 E[低风险])。这一定义在人类感染病例中具有相当大的价值,但也存在问题,因为并非所有 STEC 感染都得到了充分的特征描述和与可靠的临床信息相关联。不断出现的混合菌株暴发持续挑战我们对毒力潜力的理解,可能导致特定血清型的错误分类;一个例子是导致 2011 年德国暴发的混合菌株,STEC/EAggEC O104:H4,它可能需要替代的血清型指定。移动毒力因子在 STEC 致病谱系的逐步和并行进化中的整合与良好分类学的要求相冲突,后者将每个组的元素分为相互排斥、明确无误的亚组,并且共同包含所有可能性。因此,(血清)血清型的概念受到挑战,需要确定 STEC 的因素,这些因素绝对预测引起人类疾病的潜力。由于溶血性尿毒综合征(HUS)的定义是明确的,因此提出了用于一线公共卫生行动的 HUS 相关大肠杆菌(HUSEC)的基本和初步定义:stx2 在 eae-或 aggR-阳性大肠杆菌的背景下,其次是 stx 基因的二线亚分型,该定义将 HUSEC 精确定义为仅包括 stx2a 和 stx2d。所有其他 STEC 菌株都被认为是“低风险”STEC。